4.2 Article

Procedural efficacy and safety of standardized, ablation index guided fixed 50 W high-power short-duration pulmonary vein isolation and substrate modification using the CLOSE protocol

Journal

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
Volume 32, Issue 9, Pages 2408-2417

Publisher

WILEY
DOI: 10.1111/jce.15158

Keywords

ablation index; CLOSE protocol; EDEL; high-power short-duration; pulmonary vein isolation

Ask authors/readers for more resources

This study investigated the efficiency and safety of a fixed 50 W high-power short-duration PVI guided by Ablation index (AI) in a single-center trial. The results showed that this method can reduce total procedure time and total RF time without increasing complications.
Introduction Ablation index (AI)-guided ablation according to the CLOSE protocol is very effective in terms of chronic pulmonary vein isolation (PVI). However, the optimal radiofrequency (RF) power remains controversial. Here, we thought to investigate the efficiency and safety of an AI-guided fixed circumferential 50 W high-power short-duration (HPSD) PVI using the CLOSE protocol. Methods and Results In a single-center trial, 40 patients underwent randomized PVI using AI-guided ablation without esophageal temperature monitoring. In 20 patients a CLOSE protocol guided fixed 50 W HPSD was followed irrespective of the anatomical localization. Twenty subjects were treated according to the CLOSE protocol with standard power settings (20 W posterior and 40 W roof and anterior wall). In addition, 80 consecutive patients were treated according to the HPSD protocol to gather additional safety data. All patients underwent postprocedural esophagogastroduodenoscopy to reveal esophageal lesions (EDELs). The mean total procedural time was 80.3 +/- 22.5 in HPSD compared to control 109.1 +/- 27.4 min (p < .001). The total RF-time was significantly lower in HPSD with 1379 +/- 505 s versus control 2374 +/- 619 s (p < .001). There were no differences in periprocedural complications. EDEL occurred in 13% in the HPSD and 10% in the control group. EDEL occurring in the 50 W HSDP patients were smaller, more superficial, and had a faster healing tendency. Conclusion A fixed 50 W HPSD circumferential PVI relying on the AI and CLOSE protocol reduce the total procedure time and the total RF time, without increasing the complication rates. The incidence of EDELs was similar using 50 W at the posterior atrial wall.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

\Generation of Mature Murine Monocytes from Heterogeneous Bone Marrow and Description of Their Properties

Alexander Francke, Joerg Herold, Soenke Weinert, Ruth H. Strasser, Ruediger C. Braun-Dullaeus

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)

Article Cardiac & Cardiovascular Systems

Tetanus Toxoid-Pulsed Monocyte Vaccination for Augmentation of Collateral Vessel Growth

Joerg Herold, Alexander Francke, Soenke Weinert, Alexander Schmeisser, Katrin Hebel, Burkhart Schraven, Friedich-Wilhelm Roehl, Ruth H. Strasser, Ruediger C. Braun-Dullaeus

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Article Multidisciplinary Sciences

Isolation and Intravenous Injection of Murine Bone Marrow Derived Monocytes

Martin Wagner, Helen Koester, Christian Deffge, Soenke Weinert, Johannes Lauf, Alexander Francke, Jerry Lee, R. C. Braun-Dullaeus, Joerg Herold

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)

Article Cardiac & Cardiovascular Systems

Comparison of uninterrupted direct oral anticoagulation with vitamin-K antagonists during AF-ablation in the clinical routine. A single center register

Marian Christoph, Akram Youssef, Jan Svitil, Mathias Forkmann, Yan Huo, Thomas Gaspar, Alexander Francke, Steffen Schoen, Silvio Quick, Carsten Wunderlich

Summary: This study aims to compare the efficiency and safety of uninterrupted DOAC therapy versus VKA during AF-Ablation in real world setting, with a focus on periinterventional heparin dosage.

CLINICAL CARDIOLOGY (2021)

Article Oncology

Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model

Joerg Herold, Steven Nowak, Sawa Kostin, Jan-Marcus Daniel, Alexander Francke, Saravanan Subramaniam, Ruediger C. Braun-Dullaeus, Sandip M. Kanse

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH (2017)

Meeting Abstract Cardiac & Cardiovascular Systems

Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiency

J. Herold, C. Deffge, S. Nowak, M. Wagner, R. C. Braun-Dullaeus, S. Kostin, J. M. Daniel, A. Francke, S. Subramaniam, S. M. Kanse

CARDIOVASCULAR RESEARCH (2016)

Meeting Abstract Cardiac & Cardiovascular Systems

Factor VII-activating protease (FSAP): vascular functions and role in arteriogenesis

J. Herold, S. Nowak, A. Francke, S. Kanse, S. Weinert, R. C. Braun-Dullaeus

EUROPEAN HEART JOURNAL (2011)

Article Oncology

Transplantation of bone marrow derived monocytes: a novel approach for augmentation of arteriogenesis in a murine model of femoral artery ligation

Alexander Francke, Soenke Weinert, Ruth H. Strasser, Ruediger C. Braun-Dullaeus, Joerg Herold

AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH (2013)

No Data Available